GBI Bio Information
Summary
GBI Bio is a private company that has been in the industry for 33 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied by Karl Pinto. Its headquarters is located at Plantation, Florida, USA. The number of employees ranges from 25 to 100. The annual revenue of GBI Bio varies between 100K and 5.0M. Total funding of the company - $21.1M. To connect with GBI Bio employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
Biosimilars, Bioconjugation, Monoclonal Antibodies, Recombinant Proteins, Cell Culture, Vaccines, Antibody Drug Conjugates, Radioimmunoconjugates, Purification, QbD, Assay Development, Process Development, GMP Manufacturing, Cell Line Development, Cell Banking, Biologics
SIC Code
2836
DMA Code
Miami Metropolitan Area
Founded
1992
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Subsidiary
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1991 | Privately Held | 25 - 100 | 9.5M | $150K | |
| 1994 | Privately Held | 100 - 250 | 8.4M | $0 | |
| 1994 | Privately Held | 500 - 1.0K | 80M | $0 | |
| 1999 | Privately Held | 100 - 250 | 24.3M | $0 |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Length of Employment
